|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
238,172,000 |
Market
Cap: |
2.86(B) |
Last
Volume: |
2,152,571 |
Avg
Vol: |
1,324,858 |
52
Week Range: |
$11.61 - $23.84 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : 12.3 |
Insider 6 Months : 12.3 |
Insider 3/6 Months : 24.3 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Neogen and subsidiaries develop, manufacture and market a range of products and services dedicated to food and animal safety. Co.'s segments are: Food Safety, which is engaged in the production and marketing of diagnostic test kits and complementary products marketed to food and feed producers and processors to detect dangerous and/or unintended substances in food and animal feed; and Animal Safety, which is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, a range of agricultural biosecurity products such as rodenticides, cleaners, disinfectants and insecticides, and genomics services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
53,000 |
53,000 |
76,000 |
143,100 |
Total Buy Value |
$662,087 |
$662,087 |
$1,009,714 |
$2,211,696 |
Total People Bought |
4 |
4 |
5 |
9 |
Total Buy Transactions |
4 |
4 |
7 |
17 |
Total Shares Sold |
0 |
0 |
6,359 |
6,359 |
Total Sell Value |
$0 |
$0 |
$109,734 |
$109,734 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
4 |
4 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Quinlan Steven J. |
Vice President & CFO |
|
2021-01-07 |
4 |
OE |
$40.46 |
$377,637 |
D/D |
9,333 |
22,803 |
|
- |
|
Lilly Jason Warren |
Vice President, International |
|
2021-01-06 |
4 |
S |
$82.91 |
$913,716 |
D/D |
(11,021) |
13,611 |
|
-9% |
|
Lilly Jason Warren |
Vice President, International |
|
2021-01-06 |
4 |
OE |
$62.70 |
$797,940 |
D/D |
12,600 |
24,632 |
|
- |
|
Boehm William T |
Director |
|
2021-01-05 |
4 |
S |
$80.72 |
$242,171 |
D/D |
(3,000) |
10,479 |
|
-16% |
|
Boehm William T |
Director |
|
2021-01-05 |
4 |
OE |
$31.24 |
$93,720 |
D/D |
3,000 |
13,479 |
|
- |
|
Lilly Jason Warren |
Vice President, International |
|
2020-11-16 |
4 |
S |
$73.06 |
$1,052,914 |
D/D |
(14,378) |
12,032 |
|
-15% |
|
Lilly Jason Warren |
Vice President, International |
|
2020-11-16 |
4 |
OE |
$40.46 |
$647,440 |
D/D |
16,001 |
17,510 |
|
- |
|
Quinlan Steven J. |
Vice President & CFO |
|
2020-11-03 |
4 |
S |
$70.54 |
$470,240 |
D/D |
(6,666) |
13,470 |
|
-19% |
|
Quinlan Steven J. |
Vice President & CFO |
|
2020-11-03 |
4 |
OE |
$35.34 |
$235,576 |
D/D |
6,666 |
20,136 |
|
- |
|
Quinlan Steven J. |
Vice President & CFO |
|
2020-11-02 |
4 |
S |
$70.55 |
$56,437 |
D/D |
(800) |
13,470 |
|
-23% |
|
Quinlan Steven J. |
Vice President & CFO |
|
2020-11-02 |
4 |
OE |
$35.34 |
$28,272 |
D/D |
800 |
14,270 |
|
- |
|
Lilly Jason Warren |
Vice President |
|
2020-10-21 |
4 |
S |
$70.62 |
$470,770 |
D/D |
(6,666) |
10,409 |
|
-14% |
|
Lilly Jason Warren |
Vice President |
|
2020-10-21 |
4 |
OE |
$35.34 |
$235,576 |
D/D |
6,666 |
17,075 |
|
- |
|
Herbert James L |
Director |
|
2020-10-14 |
4 |
S |
$70.91 |
$1,796,333 |
D/D |
(25,333) |
41,951 |
|
-19% |
|
Herbert James L |
Director |
|
2020-10-14 |
4 |
OE |
$35.34 |
$895,268 |
D/D |
25,333 |
67,284 |
|
- |
|
Papesh G Bruce |
Director |
|
2020-10-01 |
4 |
OE |
$16.82 |
$67,260 |
D/D |
4,000 |
36,261 |
|
- |
|
Herbert James L |
Director |
|
2020-09-30 |
4 |
S |
$78.61 |
$1,991,361 |
D/D |
(25,333) |
41,951 |
|
-11% |
|
Herbert James L |
Director |
|
2020-09-30 |
4 |
OE |
$40.46 |
$1,025,037 |
D/D |
25,333 |
67,284 |
|
- |
|
Lilly Jason Warren |
Vice President |
|
2020-08-05 |
4 |
S |
$80.08 |
$454,932 |
D/D |
(5,681) |
10,409 |
|
-0% |
|
Lilly Jason Warren |
Vice President |
|
2020-08-05 |
4 |
OE |
$62.70 |
$356,199 |
D/D |
5,681 |
16,090 |
|
- |
|
Herbert James L |
Director |
|
2020-05-14 |
4 |
GD |
$64.45 |
$502,710 |
D/D |
7,800 |
14,072 |
|
- |
|
Lilly Jason Warren |
Vice President |
|
2020-05-05 |
4 |
S |
$64.00 |
$56,640 |
D/D |
(885) |
10,409 |
|
-24% |
|
Herbert James L |
Director |
|
2020-04-21 |
4 |
GD |
$66.13 |
$502,618 |
D/D |
7,600 |
21,872 |
|
- |
|
Herbert James L |
Director |
|
2020-04-21 |
4 |
S |
$66.13 |
$1,280,835 |
I/I |
(19,368) |
604 |
|
-22% |
|
Herbert James L |
Director |
|
2020-04-14 |
4 |
GD |
$63.23 |
$31,615 |
D/D |
500 |
29,472 |
|
- |
|
1406 Records found
|
|
Page 4 of 57 |
|
|